This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
Orders and Observations Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
This is the narrative for the resource. See also the XML, JSON or Turtle format.
Generated Narrative
Resource "example-genetics-3"
status: final
code: Further analysis ()
subject: Patient/example: Molecular Lab Patient ID: HOSP-23456 "Peter CHALMERS"
effective: 2013-04-03T15:30:10+01:00
performer: Practitioner/example: Sequence Analysis Laboratory "Adam CAREFUL"
note: The material on this page will be removed in a future release. This content is deprecated and SHOULD NOT be used. Implementers are instead directed to the ([Genomics Reporting Implementation Guide](http://hl7.org/fhir/uv/genomics-reporting/index.html)) for guidance. The EGFR p.L858R mutation has been associated with response to anti-EGFR therapy
device: Device/example
derivedFrom: Observation/example-genetics-1: ObservationForGenetics profile example 1
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.